This research report provides a comprehensive analysis of the Enasidenib Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Enasidenib Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Enasidenib Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Enasidenib Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Enasidenib Drugs market presents opportunities for various stakeholders, including Hospital, Pharmacy. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Enasidenib Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Enasidenib Drugs market was valued at US$ 74 million in 2023 and is projected to reach US$ 120.6 million by 2030, at a CAGR of 7.5% during the forecast period.
Enasidenib is a targeted therapy used to treat relapsed or refractory acute myeloid leukemia (AML) with an IDH2 mutation. Its efficacy in inhibiting the mutated IDH2 enzyme and inducing remission has driven market growth. The limited treatment options for this specific subset of AML contribute to its niche status. However, challenges include potential side effects and the need for genetic testing to identify eligible patients. The market competition is relatively small, as Enasidenib remains a targeted therapy for a specific AML subgroup. Despite challenges, the Enasidenib market offers potential for growth as healthcare providers seek effective treatments for patients with IDH2-mutated AML. Continued research and clinical advancements can further drive market expansion.
Key Features:
The research report on the Enasidenib Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Enasidenib Drugs market.
Market Overview: The report provides a comprehensive overview of the Enasidenib Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., 50mg, 100mg), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Enasidenib Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Enasidenib Drugs market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Enasidenib Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Enasidenib Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Enasidenib Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Enasidenib Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Enasidenib Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Enasidenib Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
- Enasidenib Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Market segment by Application
Global Enasidenib Drugs Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Major players covered
Outline of Major Chapters:
Chapter 1: Introduces the definition of Enasidenib Drugs, market overview.
Chapter 2: Global Enasidenib Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Enasidenib Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Enasidenib Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Enasidenib Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Enasidenib Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Enasidenib Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Enasidenib Drugs Overall Market Size
2.1 Global Enasidenib Drugs Market Size: 2023 VS 2030
2.2 Global Enasidenib Drugs Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Enasidenib Drugs Sales: 2019-2030
3 Company Landscape
3.1 Top Enasidenib Drugs Players in Global Market
3.2 Top Global Enasidenib Drugs Companies Ranked by Revenue
3.3 Global Enasidenib Drugs Revenue by Companies
3.4 Global Enasidenib Drugs Sales by Companies
3.5 Global Enasidenib Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Enasidenib Drugs Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Enasidenib Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Enasidenib Drugs Players in Global Market
3.8.1 List of Global Tier 1 Enasidenib Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Enasidenib Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Enasidenib Drugs Market Size Markets, 2023 & 2030
4.1.2 50mg
4.1.3 100mg
4.2 By Type - Global Enasidenib Drugs Revenue & Forecasts
4.2.1 By Type - Global Enasidenib Drugs Revenue, 2019-2024
4.2.2 By Type - Global Enasidenib Drugs Revenue, 2025-2030
4.2.3 By Type - Global Enasidenib Drugs Revenue Market Share, 2019-2030
4.3 By Type - Global Enasidenib Drugs Sales & Forecasts
4.3.1 By Type - Global Enasidenib Drugs Sales, 2019-2024
4.3.2 By Type - Global Enasidenib Drugs Sales, 2025-2030
4.3.3 By Type - Global Enasidenib Drugs Sales Market Share, 2019-2030
4.4 By Type - Global Enasidenib Drugs Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Enasidenib Drugs Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application - Global Enasidenib Drugs Revenue & Forecasts
5.2.1 By Application - Global Enasidenib Drugs Revenue, 2019-2024
5.2.2 By Application - Global Enasidenib Drugs Revenue, 2025-2030
5.2.3 By Application - Global Enasidenib Drugs Revenue Market Share, 2019-2030
5.3 By Application - Global Enasidenib Drugs Sales & Forecasts
5.3.1 By Application - Global Enasidenib Drugs Sales, 2019-2024
5.3.2 By Application - Global Enasidenib Drugs Sales, 2025-2030
5.3.3 By Application - Global Enasidenib Drugs Sales Market Share, 2019-2030
5.4 By Application - Global Enasidenib Drugs Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Enasidenib Drugs Market Size, 2023 & 2030
6.2 By Region - Global Enasidenib Drugs Revenue & Forecasts
6.2.1 By Region - Global Enasidenib Drugs Revenue, 2019-2024
6.2.2 By Region - Global Enasidenib Drugs Revenue, 2025-2030
6.2.3 By Region - Global Enasidenib Drugs Revenue Market Share, 2019-2030
6.3 By Region - Global Enasidenib Drugs Sales & Forecasts
6.3.1 By Region - Global Enasidenib Drugs Sales, 2019-2024
6.3.2 By Region - Global Enasidenib Drugs Sales, 2025-2030
6.3.3 By Region - Global Enasidenib Drugs Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Enasidenib Drugs Revenue, 2019-2030
6.4.2 By Country - North America Enasidenib Drugs Sales, 2019-2030
6.4.3 US Enasidenib Drugs Market Size, 2019-2030
6.4.4 Canada Enasidenib Drugs Market Size, 2019-2030
6.4.5 Mexico Enasidenib Drugs Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Enasidenib Drugs Revenue, 2019-2030
6.5.2 By Country - Europe Enasidenib Drugs Sales, 2019-2030
6.5.3 Germany Enasidenib Drugs Market Size, 2019-2030
6.5.4 France Enasidenib Drugs Market Size, 2019-2030
6.5.5 U.K. Enasidenib Drugs Market Size, 2019-2030
6.5.6 Italy Enasidenib Drugs Market Size, 2019-2030
6.5.7 Russia Enasidenib Drugs Market Size, 2019-2030
6.5.8 Nordic Countries Enasidenib Drugs Market Size, 2019-2030
6.5.9 Benelux Enasidenib Drugs Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Enasidenib Drugs Revenue, 2019-2030
6.6.2 By Region - Asia Enasidenib Drugs Sales, 2019-2030
6.6.3 China Enasidenib Drugs Market Size, 2019-2030
6.6.4 Japan Enasidenib Drugs Market Size, 2019-2030
6.6.5 South Korea Enasidenib Drugs Market Size, 2019-2030
6.6.6 Southeast Asia Enasidenib Drugs Market Size, 2019-2030
6.6.7 India Enasidenib Drugs Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Enasidenib Drugs Revenue, 2019-2030
6.7.2 By Country - South America Enasidenib Drugs Sales, 2019-2030
6.7.3 Brazil Enasidenib Drugs Market Size, 2019-2030
6.7.4 Argentina Enasidenib Drugs Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Enasidenib Drugs Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Enasidenib Drugs Sales, 2019-2030
6.8.3 Turkey Enasidenib Drugs Market Size, 2019-2030
6.8.4 Israel Enasidenib Drugs Market Size, 2019-2030
6.8.5 Saudi Arabia Enasidenib Drugs Market Size, 2019-2030
6.8.6 UAE Enasidenib Drugs Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Bristol Myers Squibb
7.1.1 Bristol Myers Squibb Company Summary
7.1.2 Bristol Myers Squibb Business Overview
7.1.3 Bristol Myers Squibb Enasidenib Drugs Major Product Offerings
7.1.4 Bristol Myers Squibb Enasidenib Drugs Sales and Revenue in Global (2019-2024)
7.1.5 Bristol Myers Squibb Key News & Latest Developments
8 Global Enasidenib Drugs Production Capacity, Analysis
8.1 Global Enasidenib Drugs Production Capacity, 2019-2030
8.2 Enasidenib Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Enasidenib Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Enasidenib Drugs Supply Chain Analysis
10.1 Enasidenib Drugs Industry Value Chain
10.2 Enasidenib Drugs Upstream Market
10.3 Enasidenib Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Enasidenib Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Enasidenib Drugs in Global Market
Table 2. Top Enasidenib Drugs Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Enasidenib Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Enasidenib Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Enasidenib Drugs Sales by Companies, (Units), 2019-2024
Table 6. Global Enasidenib Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Enasidenib Drugs Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers Enasidenib Drugs Product Type
Table 9. List of Global Tier 1 Enasidenib Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Enasidenib Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Enasidenib Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Enasidenib Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Enasidenib Drugs Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Enasidenib Drugs Sales (Units), 2019-2024
Table 15. By Type - Global Enasidenib Drugs Sales (Units), 2025-2030
Table 16. By Application ? Global Enasidenib Drugs Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Enasidenib Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Enasidenib Drugs Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Enasidenib Drugs Sales (Units), 2019-2024
Table 20. By Application - Global Enasidenib Drugs Sales (Units), 2025-2030
Table 21. By Region ? Global Enasidenib Drugs Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Enasidenib Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Enasidenib Drugs Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Enasidenib Drugs Sales (Units), 2019-2024
Table 25. By Region - Global Enasidenib Drugs Sales (Units), 2025-2030
Table 26. By Country - North America Enasidenib Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Enasidenib Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Enasidenib Drugs Sales, (Units), 2019-2024
Table 29. By Country - North America Enasidenib Drugs Sales, (Units), 2025-2030
Table 30. By Country - Europe Enasidenib Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Enasidenib Drugs Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Enasidenib Drugs Sales, (Units), 2019-2024
Table 33. By Country - Europe Enasidenib Drugs Sales, (Units), 2025-2030
Table 34. By Region - Asia Enasidenib Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Enasidenib Drugs Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Enasidenib Drugs Sales, (Units), 2019-2024
Table 37. By Region - Asia Enasidenib Drugs Sales, (Units), 2025-2030
Table 38. By Country - South America Enasidenib Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Enasidenib Drugs Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Enasidenib Drugs Sales, (Units), 2019-2024
Table 41. By Country - South America Enasidenib Drugs Sales, (Units), 2025-2030
Table 42. By Country - Middle East & Africa Enasidenib Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Enasidenib Drugs Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Enasidenib Drugs Sales, (Units), 2019-2024
Table 45. By Country - Middle East & Africa Enasidenib Drugs Sales, (Units), 2025-2030
Table 46. Bristol Myers Squibb Company Summary
Table 47. Bristol Myers Squibb Enasidenib Drugs Product Offerings
Table 48. Bristol Myers Squibb Enasidenib Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. Bristol Myers Squibb Key News & Latest Developments
Table 50. Enasidenib Drugs Production Capacity (Units) of Key Manufacturers in Global Market, 2022-2024 (Units)
Table 51. Global Enasidenib Drugs Capacity Market Share of Key Manufacturers, 2022-2024
Table 52. Global Enasidenib Drugs Production by Region, 2019-2024 (Units)
Table 53. Global Enasidenib Drugs Production by Region, 2025-2030 (Units)
Table 54. Enasidenib Drugs Market Opportunities & Trends in Global Market
Table 55. Enasidenib Drugs Market Drivers in Global Market
Table 56. Enasidenib Drugs Market Restraints in Global Market
Table 57. Enasidenib Drugs Raw Materials
Table 58. Enasidenib Drugs Raw Materials Suppliers in Global Market
Table 59. Typical Enasidenib Drugs Downstream
Table 60. Enasidenib Drugs Downstream Clients in Global Market
Table 61. Enasidenib Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Enasidenib Drugs Segment by Type in 2023
Figure 2. Enasidenib Drugs Segment by Application in 2023
Figure 3. Global Enasidenib Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Enasidenib Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Enasidenib Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. Enasidenib Drugs Sales in Global Market: 2019-2030 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Enasidenib Drugs Revenue in 2023
Figure 9. By Type - Global Enasidenib Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Enasidenib Drugs Revenue Market Share, 2019-2030
Figure 11. By Type - Global Enasidenib Drugs Sales Market Share, 2019-2030
Figure 12. By Type - Global Enasidenib Drugs Price (USD/Unit), 2019-2030
Figure 13. By Application - Global Enasidenib Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Enasidenib Drugs Revenue Market Share, 2019-2030
Figure 15. By Application - Global Enasidenib Drugs Sales Market Share, 2019-2030
Figure 16. By Application - Global Enasidenib Drugs Price (USD/Unit), 2019-2030
Figure 17. By Region - Global Enasidenib Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Enasidenib Drugs Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Enasidenib Drugs Revenue Market Share, 2019-2030
Figure 20. By Region - Global Enasidenib Drugs Sales Market Share, 2019-2030
Figure 21. By Country - North America Enasidenib Drugs Revenue Market Share, 2019-2030
Figure 22. By Country - North America Enasidenib Drugs Sales Market Share, 2019-2030
Figure 23. US Enasidenib Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Enasidenib Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Enasidenib Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Enasidenib Drugs Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Enasidenib Drugs Sales Market Share, 2019-2030
Figure 28. Germany Enasidenib Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. France Enasidenib Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Enasidenib Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Enasidenib Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Enasidenib Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Enasidenib Drugs Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Enasidenib Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Enasidenib Drugs Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Enasidenib Drugs Sales Market Share, 2019-2030
Figure 37. China Enasidenib Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Enasidenib Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Enasidenib Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Enasidenib Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. India Enasidenib Drugs Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Enasidenib Drugs Revenue Market Share, 2019-2030
Figure 43. By Country - South America Enasidenib Drugs Sales Market Share, 2019-2030
Figure 44. Brazil Enasidenib Drugs Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Enasidenib Drugs Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Enasidenib Drugs Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Enasidenib Drugs Sales Market Share, 2019-2030
Figure 48. Turkey Enasidenib Drugs Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Enasidenib Drugs Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Enasidenib Drugs Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Enasidenib Drugs Revenue, (US$, Mn), 2019-2030
Figure 52. Global Enasidenib Drugs Production Capacity (Units), 2019-2030
Figure 53. The Percentage of Production Enasidenib Drugs by Region, 2023 VS 2030
Figure 54. Enasidenib Drugs Industry Value Chain
Figure 55. Marketing Channels
